> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Roadmap to Reduce Drug Safety Animal Testing
- URL: https://www.fdaweb.com/roadmap-to-reduce-drug-safety-animal-testing/
- Published: 2018-02-01T12:00:00.000Z
- Updated: 2026-09-14T23:19:11.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5140654

FDA was one of 16 federal agencies that developed a “strategic roadmap” with a new framework for safety testing of drugs and chemicals that will provide more human-relevant toxicology data while reducing the use of animals. The National Toxicology Program [published](https://www.niehs.nih.gov/news/newsroom/releases/2018/january30/index.cfm?ref=fdaweb.com) the roadmap 1/30.

The agencies say the roadmap was developed to guide application of new technologies, such as high-throughput screening, tissue chips, and computational models, to toxicity testing of chemicals and medical products. Three strategic goals identified as being needed for progress are: 

- connecting new test method developers with end users;
- promoting flexible approaches for establishing confidence in new methods; and
- encouraging adoption of new methods by federal agencies and regulated industries once validated.

 Objectives described in the roadmap identify activities that should be undertaken by regulatory agencies, test method developers, regulated industries, funding agencies, and other stakeholders to achieve the stated goals.